Evidence map›Paper›PMID 36129874›Full record

ArticlePloS one2022

HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule.

Shashi Shrivastav, Hewang Lee, Koji Okamoto, Huiyan Lu, Teruhiko Yoshida, Khun Zaw Latt, Hidefumi Wakashin, James L T Dalgleish, Erik H Koritzinsky, Peng Xu and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Progression of HIV-1 CKDs: Viral Load VersusKidney international reports · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Shashi ShrivastavKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
Hewang LeeKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
Koji OkamotoKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
Huiyan LuKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
Teruhiko YoshidaKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.ORCID 0000-0002-2049-7347
Khun Zaw LattKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
Hidefumi WakashinKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
James L T DalgleishKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.ORCID 0000-0002-2053-8786
Erik H KoritzinskyKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.
Peng XuDepartment of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
Laureano D AsicoDepartment of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC, United States of America.
Joon-Yong ChungExperimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.ORCID 0000-0001-5041-5982
Stephen HewittExperimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.
John J GildeaDepartment of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
Robin A FelderDepartment of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
Pedro A JoseDepartment of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC, United States of America.ORCID 0000-0003-1507-7556
Avi Z RosenbergDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
Mark A KnepperEpithelial Systems Biology Laboratory, Systems Biology Center, Division of Intramural Research, NHLBI, NIH, Bethesda, Maryland, United States of America.
Tomoshige KinoLaboratory for Molecular and Genomic Endocrinology, Division of Translational Medicine, Sidra Medicine, Doha, Qatar.
Jeffrey B KoppKidney Disease Section, Kidney Diseases Branch, NIDDK, NIH, Bethesda, Maryland, United States of America.ORCID 0000-0001-9052-186X
National Institute of Diabetes and Digestive and Kidney Diseases · USGeorge Washington University · USUniversity of Virginia · USCenter for Cancer Research · USJohns Hopkins University · US

Funding

Focal segmental glomerulosclerosis: HIV-associated nephropathyZIADK043411 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HEYMANN, JURGEN · 2009 to 2024
$7.3M
Intramural NIH HHS ZIA DK043411
6 · The paper itself

Abstract

HIV-associated nephropathy (HIVAN) impairs functions of both glomeruli and tubules. Attention has been previously focused on the HIVAN glomerulopathy. Tubular injury has drawn increased attention because sodium wasting is common in hospitalized HIV/AIDS patients. We used viral protein R (Vpr)-transgenic mice to investigate the mechanisms whereby Vpr contributes to urinary sodium wasting. In phosphoenolpyruvate carboxykinase promoter-driven Vpr-transgenic mice, in situ hybridization showed that Vpr mRNA was expressed in all nephron segments, including the distal convoluted tubule. Vpr-transgenic mice, compared with wild-type littermates, markedly increased urinary sodium excretion, despite similar plasma renin activity and aldosterone levels. Kidneys from Vpr-transgenic mice also markedly reduced protein abundance of the Na+-Cl- cotransporter (NCC), while mineralocorticoid receptor (MR) protein expression level was unchanged. In African green monkey kidney cells, Vpr abrogated the aldosterone-mediated stimulation of MR transcriptional activity. Gene expression of Slc12a3 (NCC) in Vpr-transgenic mice was significantly lower compared with wild-type mice, assessed by both qRT-PCR and RNAScope in situ hybridization analysis. Chromatin immunoprecipitation assays identified multiple MR response elements (MRE), located from 5 kb upstream of the transcription start site and extending to the third exon of the SLC12A3 gene. Mutation of MRE and SP1 sites in the SLC12A3 promoter region abrogated the transcriptional responses to aldosterone and Vpr, indicating that functional MRE and SP1 are required for the SLC12A3 gene suppression in response to Vpr. Thus, Vpr attenuates MR transcriptional activity and inhibits Slc12a3 transcription in the distal convoluted tubule and contributes to salt wasting in Vpr-transgenic mice.

Indexed as

Gene Products, vprHIV-1AldosteroneAnimalsChlorocebus aethiopsKidney Tubules, DistalMiceMice, TransgenicPhosphoenolpyruvateReceptors, MineralocorticoidReninRNA, MessengerSodiumSodium ChlorideSodium Chloride SymportersSolute Carrier Family 12, Member 3AldosteroneGene Products, vprPhosphoenolpyruvateReceptors, MineralocorticoidReninRNA, MessengerSodiumSodium ChlorideSodium Chloride SymportersSolute Carrier Family 12, Member 3Thiazides

Identifiers

PMID36129874
PMCPMC9491550
OpenAlexW4296794289

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.